Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

Role of changes in renal hemodynamics and P-450 metabolites of arachidonic acid in the reversal of one-kidney, one clip hypertension.

Zou AP, Muirhead EE, Cowley AW, Mattson DL, Falck JR, Jiang J, Roman RJ.

J Hypertens. 1995 May;13(5):557-66.

PMID:
7561014
2.

Purification of class I medullipins from the venous effluent of isolated normal kidneys perfused under high pressure with saline.

Brooks B, Byers LW, Muirhead EE, Muirhead M, Pitcock JA, Maddipati KR, Maxey KM.

Blood Press. 1994 Nov;3(6):407-17.

PMID:
7704290
3.

Secretion of medullipin I by the kidney involves the cytochrome P-450 enzyme system.

Muirhead EE, Brooks B, Byers LW.

J Hypertens. 1994 Feb;12(2):155-8.

PMID:
8021466
4.

Renal vasodepressor mechanisms: the medullipin system.

Muirhead EE.

J Hypertens Suppl. 1993 Dec;11(5):S53-8. Review. Erratum in: J Hypertens Suppl 1994 Apr;12(4):following H14.

PMID:
8158434
5.

Lipomedullipinoma: a source of hypermedullipinemia.

Muirhead EE, Streeten DH, Byers LW, Brooks B, Schroeder ET.

Blood Press. 1993 Sep;2(3):183-8.

PMID:
8205311
6.

Persistent hypotension associated with hypermedullipinemia: a new syndrome.

Muirhead EE, Streeten DH, Brooks B, Schroeder ET, Byers LW.

Blood Press. 1992 Oct;1(3):138-48.

PMID:
1345046
7.

An alternate road.

Muirhead EE.

Blood Press. 1992 Oct;1(3):132-4. No abstract available.

PMID:
1345044
8.

Secretion of medullipin I by the kidney requires oxygen.

Muirhead EE, Brooks B, Byers LW.

J Hypertens. 1992 Sep;10(9):963-7.

PMID:
1328377
9.

Biologic differences between vasodilator prostaglandins and medullipin I.

Muirhead EE, Brooks B, Byers LW.

Am J Med Sci. 1992 Feb;303(2):86-9. Erratum in: Am J Med Sci 1992 Jul;304(1):37.

PMID:
1539615
10.

Medullipin system. Generation of medullipin II by isolated kidney-liver perfusion.

Muirhead EE, Brooks B, Byers LW, Brown P, Pitcock JA.

Hypertension. 1991 Nov;18(5 Suppl):III158-63.

PMID:
1937680
11.

The medullipin system of blood pressure control.

Muirhead EE.

Am J Hypertens. 1991 Oct;4(10 Pt 2):556S-568S. Review.

PMID:
1741992
12.

Antihypertensive action of medullipin I given by mouth.

Muirhead EE, Brooks B, Byers LW, Toba K, Share L.

Hypertension. 1991 Jun;17(6 Pt 2):1092-6.

PMID:
2045154
13.

Secretion of medullipin I by isolated kidneys perfused under elevated pressure.

Muirhead EE, Brooks B, Byers LW, Brown P, Pitcock JA.

Clin Exp Pharmacol Physiol. 1991 Jun;18(6):409-17.

PMID:
1914243
14.

Discovery of the renomedullary system of blood pressure control and its hormones.

Muirhead EE.

Hypertension. 1990 Jan;15(1):114-6. No abstract available.

PMID:
2403977
15.
16.

Isolation and culture of juxtaglomerular and renomedullary interstitial cells.

Muirhead EE, Rightsel WA, Pitcock JA, Inagami T.

Methods Enzymol. 1990;191:152-67. No abstract available.

PMID:
2074755
17.

Histopathology of severe renal vascular damage in blacks.

Muirhead EE, Pitcock JA.

Clin Cardiol. 1989 Dec;12(12 Suppl 4):IV58-65.

18.

Renal and circulatory effects of medullipin I, as studied in the in-vivo cross-circulated isolated kidney and intact Wistar-Kyoto (WKY) rat.

Karlström G, Arnman V, Bergström G, Muirhead EE, Rudenstam J, Göthberg G.

Acta Physiol Scand. 1989 Dec;137(4):521-33.

PMID:
2603751
19.

Biologic contrasts between medullipin I and vasoactive glyceryl compounds.

Muirhead EE, Byers LW, Brooks B, Brown P, Pitcock JA.

Am J Med Sci. 1989 Aug;298(2):93-103.

PMID:
2764021
20.

The renal antihypertensive endocrine function: its relation to cytochrome P-450.

Muirhead EE, Byers LW, Capdevila J, Brooks B, Pitcock JA, Brown PS.

J Hypertens. 1989 May;7(5):361-9.

PMID:
2504817
21.

Glycosaminoglycans of the rat renomedullary interstitium: ultrastructural and biochemical observations.

Pitcock JA, Lyons H, Brown PS, Rightsel WA, Muirhead EE.

Exp Mol Pathol. 1988 Dec;49(3):373-87.

PMID:
2461872
22.

The renomedullary system of blood pressure control.

Muirhead EE.

Am J Med Sci. 1988 Apr;295(4):231-3. Review. No abstract available.

PMID:
3284345
23.

Conversion of medullipin I by the liver.

Muirhead EE, Brooks B, Byers LW, Pitcock JA, Brown PS.

Trans Assoc Am Physicians. 1988;101:226-34. No abstract available.

PMID:
3269681
24.

Selachyl alcohol as an oral antihypertensive agent: a preliminary note.

Muirhead EE, Byers LW, Brooks B, Pitcock JA, Brown P, Dowell R.

Am J Med Sci. 1987 Nov;294(5):384-7.

PMID:
3425587
25.

1986 Ward Burdick Award lecture. Pathology as an investigative discipline.

Muirhead EE.

Am J Clin Pathol. 1987 Apr;87(4):543-53. No abstract available. Erratum in: Am J Clin Pathol 1987 Aug;88(2):253.

PMID:
3548323
26.

The reno-hepatic axis of blood pressure control: further studies.

Muirhead EE, Byers LW, Brooks B, Dowell R.

Am J Med Sci. 1987 Mar;293(3):177-81.

PMID:
3551610
27.
28.

Renal medullary system of blood pressure control.

Muirhead EE, Pitcock JA, Brooks B.

J Hypertens Suppl. 1986 Oct;4(4):S27-32. Review.

PMID:
3534182
29.

The liver converts the antihypertensive hormone of the kidney. The renohepatic axis.

Muirhead EE, Byers LW, Brooks B, Dowell R.

Hypertension. 1986 Jun;8(6 Pt 2):II117-22.

PMID:
3721554
30.

B2 bradykinin receptor-like binding in rat renomedullary interstitial cells.

Fredrick MJ, Abel FC, Rightsel WA, Muirhead EE, Odya CE.

Life Sci. 1985 Jul 29;37(4):331-8.

PMID:
2861552
31.

The antihypertensive function of the kidney. Its elucidation by captopril plus unclipping.

Muirhead EE, Pitcock JA, Nasjletti A, Brown P, Brooks B.

Hypertension. 1985 May-Jun;7(3 Pt 2):I127-35.

PMID:
2581897
32.

The morphology and antihypertensive effect of renomedullary interstitial cells derived from Dahl sensitive and resistant rats.

Pitcock JA, Brown PS, Brooks B, Rapp JP, Rightsel W, Muirhead EE.

Exp Mol Pathol. 1985 Feb;42(1):29-43.

PMID:
3967749
33.

The renal antihypertensive hormone.

Muirhead EE, Pitcock JA.

J Hypertens. 1985 Feb;3(1):1-8. Review. No abstract available.

PMID:
3889145
34.

Conversion of the antihypertensive neutral renomedullary lipid by the liver.

Muirhead EE, Byers LW, Brooks B.

Trans Assoc Am Physicians. 1985;98:269-74. No abstract available.

PMID:
3842198
35.

Morphometric studies on the rat renal papilla of resistant and sensitive strains in partial nephrectomy salt hypertension.

Pitcock JA, Brown PS, Brooks B, Susic D, Kentera D, Rapp JP, Muirhead EE.

J Hypertens. 1984 Aug;2(4):419-25.

PMID:
6530549
36.

Regional hemodynamic effects of antihypertensive renomedullary lipids in conscious rats.

Faber JE, Barron KW, Bonham AC, Lappe R, Muirhead EE, Brody MJ.

Hypertension. 1984 Jul-Aug;6(4):494-502.

PMID:
6746083
37.

Antihypertensive polar and neutral renopapillary lipids. Which is a hormone?

Muirhead EE, Byers LW, Folkow B, Göthberg G, Thorén P, Brooks B.

Hypertension. 1983 Nov-Dec;5(6 Pt 3):V61-5.

PMID:
6654466
38.

Cardiovascular effects of antihypertensive renomedullary lipids (APRL and ANRL).

Muirhead EE, Folkow B, Byers LW, Aus G, Friberg P, Göthberg G, Nilsson H, Thoren P.

Acta Physiol Scand. 1983 Mar;117(3):465-7. No abstract available.

PMID:
6880807
39.

Cardiovascular effects of antihypertensive polar and neutral renomedullary lipids.

Muirhead EE, Folkow B, Byers LW, Desiderio DM Jr, Thorén P, Göthberg G, Dow AW, Brooks B.

Hypertension. 1983 Mar-Apr;5(2 Pt 2):I112-8.

PMID:
6826221
40.

Blockade of alpha-adrenergic receptors by analogues of phosphatidylcholine.

Smith KA, Cornett LE, Norris JS, Byers LW, Muirhead EE.

Life Sci. 1982 Nov 1;31(18):1891-902. Review.

PMID:
6129556
41.

Morphometric studies of the renomedullary interstitial cells of Dahl hypertension-prone and hypertension-resistant rats.

Pitcock JA, Brown PS, Rapp JP, Crofton J, Muirhead EE.

Am J Pathol. 1982 Oct;109(1):123-8.

42.

Long-term captopril therapy: evolving hemodynamic effects.

Sullivan JM, Taylor JC, Patrick DR, Johnson JG, Ratts TE, Muirhead EE.

J Clin Pharmacol. 1982 Oct;22(10):450-8.

PMID:
6757280
43.

Juxtaglomerular cells grown as monolayer cell culture contain renin, angiotensin I-converting enzyme, and angiotensin I and II/III.

Rightsel WA, Okamura T, Inagami T, Pitcock JA, Takii Y, Brooks B, Brown P, Muirhead EE.

Circ Res. 1982 Jun;50(6):822-9.

PMID:
6282494
44.

Effect of platelet-activating factor (PAF) on human platelets.

Chesney CM, Pifer DD, Byers LW, Muirhead EE.

Blood. 1982 Mar;59(3):582-5.

45.

Derivation of antihypertensive neutral renomedullary lipid from renal venous effluent.

Muirhead EE, Byers LW, Desiderio DM Jr, Pitcock JA, Brooks B, Brown PS, Brosius WL.

J Lab Clin Med. 1982 Jan;99(1):64-75.

PMID:
6798154
46.

Cultured juxtaglomerular cells cause hypertension by secreting angiotensin.

Muirhead EE, Rightsel WA, Pitcock JA, Inagami T, Okamura T, Takii Y, Goodfriend TL, Sealey JE, Brooks B, Brown P.

Trans Assoc Am Physicians. 1982;95:110-9.

PMID:
6763810
47.

Derivation of neutral antihypertensive lipid from renal venous effluent in rats.

Muirhead EE, Byers LW, Pitcock JA, Desiderio DM, Brooks B, Brown P, Brosius WL.

Clin Sci (Lond). 1981 Dec;61 Suppl 7:331s-333s.

PMID:
7318334
48.

Degranulation of renomedullary interstitial cells during reversal of hypertension.

Pitcock JA, Brown PS, Byers W, Brooks B, Muirhead EE.

Hypertension. 1981 Nov-Dec;3(6 Pt 2):II-75-80.

PMID:
7298142
49.

Analogs of phosphatidylcholine: alpha-adrenergic antagonists from the renal medulla.

Smith KA, Prewitt RL Jr, Byers LW, Muirhead EE.

Hypertension. 1981 Jul-Aug;3(4):460-70.

PMID:
6118327
50.

Antihypertensive lipids from the kidney: alkyl ether analogs of phosphatidylcholine.

Muirhead EE, Byers LW, Desiderio DM, Brooks B, Brosius WM.

Fed Proc. 1981 Jun;40(8):2285-90.

PMID:
7016598

Supplemental Content

Loading ...
Support Center